Neurotraining for Concussion

Not currently recruiting at 1 trial location
TL
MH
Overseen ByMing-Xiong Huang, Ph.D.
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Perception Dynamics Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new approach to improve brain functions such as working memory and attention in individuals with mild traumatic brain injury (mTBI), commonly known as a concussion. Participants will engage in PATH neurotraining, which consists of computer-based exercises designed to enhance memory and processing speed. Researchers will test three different training schedules to determine the most effective routine. Individuals who have experienced one or more concussions and have ongoing memory issues might be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to innovative research that could lead to new treatment options for mTBI.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you have a diagnosis of epilepsy, seizure disorder, major depressive disorder, or severe anxiety, you may not be eligible to participate.

What prior data suggests that this neurotraining is safe for mTBI patients?

Research shows that PATH neurotraining is generally well-tolerated. Studies have found that participants in PATH neurotraining have experienced improvements in cognitive skills, such as memory and focus, without major side effects. The treatment involves exercises to retrain brain pathways, akin to a mental workout routine.

Although studies do not specifically mention negative effects, the absence of such reports suggests the treatment is relatively safe. As this is an early-phase trial, the researchers are still collecting safety data, but initial results indicate that participants have not encountered major problems.12345

Why are researchers excited about this trial?

Researchers are excited about PATH neurotraining for concussions because it offers a non-invasive, cognitive approach to recovery, unlike the typical rest and gradual return to activities. This technique uses adaptive computer-based exercises that adjust in difficulty to enhance visual and memory skills, potentially speeding up cognitive recovery. By combining tasks that challenge both visual contrast and memory recall, PATH neurotraining aims to improve brain function more effectively than current methods. Additionally, the flexibility in training frequency—ranging from once to three times a week—allows personalization to fit individual needs and schedules.

What evidence suggests that this trial's treatments could be effective for mTBI?

Research has shown that PATH neurotraining, one of the treatments studied in this trial, can improve mental skills like memory and focus, often affected after a concussion. One study found that participants using PATH improved their visual memory by 35%, outperforming other methods tested. PATH retrains the brain to process visual information more accurately and quickly. This enhancement in visual timing can boost other related mental skills. Overall, PATH neurotraining appears promising for helping individuals with mild brain injuries regain important mental abilities. Participants in this trial will receive PATH neurotraining combined with digit memory exercises at varying frequencies to assess its effectiveness.23467

Who Is on the Research Team?

TL

Teri Lawton, Ph.D.

Principal Investigator

Perception Dynamics Institute

Are You a Good Fit for This Trial?

This trial is for individuals aged 18-60 who have had a mild traumatic brain injury (mTBI) and score between 19-25 on the MoCA test. Participants must read English, have corrected 20/20 vision, and be able to commit time to complete the study. Those with post-traumatic amnesia over 24 hours, recent mTBI (<3 months), or certain cognitive impairments are excluded.

Inclusion Criteria

Has corrected 20/20 visual acuity for PATH training
Fluent in English to follow instructions
Can sign and understand the informed consent form
See 4 more

Exclusion Criteria

Presence of extensive metal dental hardware or other metal objects in head, neck, or face areas that cause artifacts in MEG data and health concerns in MRI data and are not removable during pre-processing
Claustrophobia or presence of a cardiac pacemaker for MEG/MRI exams.
I have experienced memory loss for more than a day after an injury.
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
Phone screening

Treatment

Participants undergo PATH, N-Back WM, or Sham neurotraining for cognitive improvement

12 weeks
36 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Open-label extension (optional)

Participants may opt into continuation of treatment long-term

Long-term

What Are the Treatments Tested in This Trial?

Interventions

  • N-Back Working Memory Training
  • Orientation Discrimination
  • PATH neurotraining
Trial Overview The study tests PATH neurotraining's ability to improve working memory and attention in patients with mTBI. It aims to establish if this training can rapidly and effectively remediate cognitive issues caused by concussions.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: PATH+DM neurotraining two times a week for 36 30-minute sessionsExperimental Treatment1 Intervention
Group II: PATH+DM neurotraining three times a week for 36 30-minute sessionsExperimental Treatment1 Intervention
Group III: PATH+DM neurotraining once a week for 36 30-minute sessionsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Perception Dynamics Institute

Lead Sponsor

Trials
2
Recruited
80+

University of South Alabama

Collaborator

Trials
44
Recruited
15,800+

University of California, San Diego

Collaborator

Trials
1,215
Recruited
1,593,000+

University of California, Riverside

Collaborator

Trials
33
Recruited
14,400+

Published Research Related to This Trial

A review of 14 studies indicates that EEG-based neurofeedback training significantly improves upper limb rehabilitation in stroke patients compared to traditional treatments, suggesting its effectiveness in occupational therapy.
Combining EEG neurofeedback with occupational therapy may enhance rehabilitation outcomes, particularly for outpatients, highlighting the need for customized treatment approaches.
Electroencephalogram-based neurofeedback training in persons with stroke: A scoping review in occupational therapy.Yoo, IG.[2021]
A study involving 25 patients aged 12-20 with post-concussion syndrome showed that a multimodal physical therapy approach significantly reduced symptoms, as indicated by a decrease in the Post-Concussion Symptom Scale scores from an average of 18.2 to 9.1 after treatment.
The therapy also improved physical performance, with a 23% increase in maximum symptom-free heart rate during exercise and a 52% reduction in balance errors, demonstrating both safety and efficacy in managing post-concussion symptoms.
Multimodal impairment-based physical therapy for the treatment of patients with post-concussion syndrome: A retrospective analysis on safety and feasibility.Grabowski, P., Wilson, J., Walker, A., et al.[2022]
In a study involving 360 veterans with moderate to severe traumatic brain injury (TBI), both cognitive-didactic and functional-experiential rehabilitation approaches showed similar long-term outcomes in terms of overall functional independence and return to work or school after one year.
However, participants receiving cognitive-didactic treatment demonstrated significantly better short-term cognitive function immediately after treatment, particularly benefiting younger individuals in terms of returning to work or school, while older participants with more education fared better in independent living with the functional-experiential approach.
Rehabilitation of traumatic brain injury in active duty military personnel and veterans: Defense and Veterans Brain Injury Center randomized controlled trial of two rehabilitation approaches.Vanderploeg, RD., Schwab, K., Walker, WC., et al.[2009]

Citations

Retraining Neural Pathways to Improve Cognitive Skills after a ...PATH is hypothesized to improve the precision in timing of visual events, and in turn improve cognitive functions that rely upon visual timing, such as working ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40217723/
Retraining Dorsal Visual Pathways Improves Cognitive Skills ...Results: On average, the PATH group exhibited a 35% improvement in VWM, compared to 15% for ReCollect and 5% for OD. A repeated-measures ANOVA ...
Retraining Neural Pathways Improves Cognitive Skills After ...Research has found that the effects of a mTBI reflect disruptions of the neural networks for attention and working memory. After a mTBI, patients have ...
Retraining Neural Pathways Improves Cognitive Skills After ...The proposed study tests the efficacy (Phase II) of 36 30-minute training sessions of PATH neurotraining followed by digit memory exercises to improve ...
PATH neurotrainingLearning to See Quickly Improves Thinking Abilities: Why PATH neurotraining is essential for improving brain function and ease of learning.
Retraining Dorsal Visual Pathways Improves Cognitive Skills ...Therefore, PATH neurotraining improved cognitive abilities not related to movement discrimination, and improved everyday cognitive performance ...
(PDF) Retraining Dorsal Visual Pathways Improves ...Results: On average, the PATH group exhibited a 35% improvement in VWM, compared to 15% for ReCollect and 5% for OD. A repeated-measures ANOVA found that ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security